MORAb 028

N/A

Report date: 2022/11/25 17:25:24

Base Information

Drug NameMORAb 028

Drug Alias NameMORAb-028MT 228

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionDisialoganglioside GD2 inhibitors

TargetsDisialoganglioside GD2

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMicromet Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMorphotek Inc

Active IndicationsN/A

Inactive IndicationsMelanoma

ATC CodeN/A